BIOTALYS NV (BTLS.BR) Stock Earnings & Estimates
Europe - EBR:BTLS - BE0974386188 - Common Stock
4.88 EUR
+0.03 (+0.62%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 125.00% | N/A 24.69% | |||||||
| EBITDA YoY % growth | -8.65M | -12.24M -41.50% | -16.61M -35.70% | -20.956M -26.16% | -19.21M 8.33% | -11.17M 41.85% | N/A -25.10% | N/A 29.20% | N/A -49.83% | |
| EBIT YoY % growth | -9.24M | -13.28M -43.72% | -18.08M -36.14% | -22.531M -24.62% | -21M 6.80% | -13M 38.10% | N/A -16.12% | N/A 27.48% | N/A -44.41% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 2.44% | N/A 5.00% | N/A | N/A 1.76% | N/A 30.36% | N/A -44.87% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0.89% | 53.62% |
| Revenue | N/A | N/A | 0% | 0% |